PANX1 and migraine disorder: These advances open the exciting possibility of developing Panx1 inhibitors as migraine prophylactic drugs; especially considering some Panx1 inhibitors such as carbenoxolone, probenecid and mefloquine are already clinically registered medicines (Yeung et al., 2020).